The events surrounding the removal of encainide and flecainide from the Cardiac Arrhythmia Suppression Trial (CAST) and why CAST is continuing with moricizine

J Am Coll Cardiol. 1990 Jan;15(1):243-5. doi: 10.1016/0735-1097(90)90209-8.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anilides / adverse effects*
  • Anti-Arrhythmia Agents / adverse effects
  • Anti-Arrhythmia Agents / therapeutic use*
  • Arrhythmias, Cardiac / prevention & control*
  • Encainide
  • Flecainide / adverse effects*
  • Humans
  • Mass Media
  • Moricizine
  • National Institutes of Health (U.S.)
  • Phenothiazines / therapeutic use*
  • Randomized Controlled Trials as Topic
  • United States
  • United States Food and Drug Administration

Substances

  • Anilides
  • Anti-Arrhythmia Agents
  • Phenothiazines
  • Moricizine
  • Flecainide
  • Encainide